In this section
The EpiPro project uses epigenetic profiling to detect disease-specific DNA methylation signatures across the genome which are specific for rare disorders
Test details
Manchester EpiPro uses DNA methylation array technology with the EpiSign Knowledge Database to identify disease-specific DNA methylation signatures or epivariants in patients with selected rare conditions. This service can be used to resolve variants of uncertain significance or as a direct diagnostic tool.
Test ordering
The EpiPro test request form can be completed electronically or printed and completed by hand.
Test details
Manchester EpiPro uses DNA methylation array technology with the EpiSign Knowledge Database to identify disease-specific episignatures and epivariants in patients with selected rare conditions. This service can be used to resolve variants of uncertain significance or as a direct diagnostic tool.
Rare disease methylation array panel content can be found here
Questions?
Please email mft.epipro.nwglh-lab@nhs.net
This service is not currently a UKAS accredited service